Citadel Investment Advisory’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,190
Closed -$154K 83
2024
Q3
$154K Sell
17,190
-2,625
-13% -$27K 0.08% 76
2024
Q2
$240K Sell
19,815
-3,200
-14% -$54.3K 0.14% 70
2024
Q1
$499K Sell
23,015
-804
-3% -$17.9K 0.28% 59
2023
Q4
$622K Sell
23,819
-870
-4% -$19.4K 0.38% 53
2023
Q3
$549K Hold
24,689
0.36% 52
2023
Q2
$703K Sell
24,689
-180
-0.7% -$5.86K 0.45% 43
2023
Q1
$860K Hold
24,869
0.59% 41
2022
Q4
$929K Sell
24,869
-340
-1% -$12.8K 0.64% 38
2022
Q3
$792K Buy
25,209
+750
+3% +$27.8K 0.6% 38
2022
Q2
$927K Sell
24,459
-2,309
-9% -$99.3K 0.63% 40
2022
Q1
$1.2M Sell
26,768
-805
-3% -$39.6K 0.7% 38
2021
Q4
$1.44M Sell
27,573
-81
-0.3% -$3.92K 0.84% 33
2021
Q3
$1.3M Hold
27,654
0.81% 34
2021
Q2
$1.46M Sell
27,654
-75
-0.3% -$4.03K 0.9% 31
2021
Q1
$1.52M Hold
27,729
1% 28
2020
Q4
$1.11M Buy
+27,729
New +$1.07M 0.79% 32

Other funds holding WBA

Citadel Investment Advisory's WBA Position: Q4 2024 in Review

Citadel Investment Advisory sold out of Walgreens Boots Alliance (WBA) in Q4 2024, closing a stake of 17,190 shares — an estimated $154K sold.

Citadel Investment Advisory first reported a position in WBA in Q4 2020 and held it in 16 quarters. The position peaked at $1.52M in Q1 2021. 881 funds tracked by Wall St. Rank hold WBA as of Q4 2024.

  • Citadel Investment Advisory reported no remaining Walgreens Boots Alliance position as of Q4 2024 after selling out during the quarter.
  • Citadel Investment Advisory sold 17,190 Walgreens Boots Alliance shares in Q4 2024, an estimated $154K.
  • Citadel Investment Advisory first reported a position in Walgreens Boots Alliance in Q4 2020 and held it in 16 quarters.
  • Citadel Investment Advisory's Walgreens Boots Alliance position peaked at $1.52M in Q1 2021.
  • 881 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2024.

Based on Citadel Investment Advisory's 13F filing for Q4 2024, filed 24 Jan 2025.